Bryce Point Capital, LLC Atri Cure, Inc. Transaction History
Bryce Point Capital, LLC
- $345 Billion
- Q4 2024
A detailed history of Bryce Point Capital, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Bryce Point Capital, LLC holds 16,760 shares of ATRC stock, worth $709,953. This represents 0.15% of its overall portfolio holdings.
Number of Shares
16,760Holding current value
$709,953% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding ATRC
# of Institutions
221Shares Held
49.3MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.65MShares$197 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$196 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.84MShares$162 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$120 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$118 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.97B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...